FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for an extended-release version of lithium carbonate (Lithium Carbonate ER) from Glenmark Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium carbonate ER (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE ER (LITHIUM CARBONATE)